Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,905 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05829629RecruitingPhase 1
Test of an HPV vaccine-like treatment for HPV16 in women
This Phase 1 study tests FluBHPVE6E7, a new treatment designed to help the immune system respond to HPV16. It mainly checks safety and the best dose, and may help your body clear or control HPV over time.
BratislavaAges 18–49 - NCT07402512RecruitingPhase 3
Study of deuremidevir for RSV in infants and young children
This trial is testing a new medicine called deuremidevir for babies and young children with RSV infection. It is for those who have symptoms like fast breathing and wheezing, and have been sick for no more than 96 hours.
Xiamen, FujianAges 1 month–3 years - NCT07401680RecruitingPhase 1
Stool transplant for active ulcerative colitis
This trial tests whether a stool transplant (fecal microbiota transplantation) can help manage active ulcerative colitis. You would receive a transplant from a healthy donor to see if it improves your symptoms.
Calgary, AlbertaAges 18 years+ - NCT07405554RecruitingPhase 2
Zinc with botox for overactive bladder
This trial tests whether taking zinc along with a botox injection (a standard treatment) can better reduce sudden, strong urges to urinate in women with overactive bladder who haven't gotten relief from other treatments.
Skokie, IllinoisAges 21–100 - NCT07401212Recruiting
Fiber-boosting program for parents of preschoolers
This study tests a program to help parents add more fiber to their preschooler's diet. It may be a good fit if your child eats less fiber than recommended and is generally healthy.
Reading, BerkshireAges 3–5 - NCT07398898Recruiting
Can glasses and headphones reduce dental anxiety?
This study tests whether special glasses that show relaxing images and noise-cancelling headphones can help adults feel less anxious during common dental procedures like cleanings, fillings, or extractions.
Warsaw, Masovian VoivodeshipAges 18 years+ - NCT07405216RecruitingPhase 4
SGLT2 inhibitors for teens with early kidney disease
This trial tests whether a type of medicine called SGLT2 inhibitors can help teenagers with early-stage chronic kidney disease. It looks at how safe and effective these drugs are for slowing down kidney damage.
Aguascalientes, AguascalientesAges 14–18 - NCT07402902Enrolling by invitation
Caffeine timing and fat burning during exercise
This trial looks at how different caffeine strategies affect how much fat you burn during exercise. If you are a healthy, active adult, this study could help you understand how caffeine might improve your workouts.
Fuenlabrada, MadridAges 18–50 - NCT07400367Recruiting
Probiotics and lifestyle changes for fatty liver disease
This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.
New Taipei CityAges 18–80 - NCT07407400RecruitingPhase 4
Sleep medication to prevent confusion in older ICU patients
This study tests whether a sleep medication called lemborexant can help older patients in the ICU sleep better and prevent post-surgery confusion. It may be a good fit if you are over 65 and will be in the ICU for at least two days after surgery.
BangkokAges 65 years+ - NCT07398287RecruitingPhase 2
Menthol for breathlessness in interstitial lung disease
This study tests if inhaling L-menthol can help reduce breathlessness in people with interstitial lung disease. You will cycle while breathing menthol or a placebo to see if it makes breathing easier.
Karlskrona, Blekinge CountyAges 18 years+ - NCT06531863RecruitingEarly Phase 1
Curcumin and green tea supplement for mood improvement
This study tests whether taking curcumin (found in turmeric) and EGCG (found in green tea) can improve mood and increase a brain protein called BDNF, which may help with depression. It is for adults ages 18 to 50 with mild to moderate depression symptoms.
Auburn, AlabamaAges 18–50 - NCT06827444Recruiting
How attention changes the placebo effect
This study looks at how your attention influences the placebo effect—the real benefits you can feel from a treatment that has no active ingredient. It may help us understand why some people respond better to placebos, which could improve future treatments.
Milan, MilanoAges 19–99 - NCT04912596Recruiting
Tested albuterol inhaler compared to a standard inhaler for mild asthma
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
AhmedabadAges 20–65 - NCT05985850RecruitingPhase 2
Can cannabis help with opioid addiction treatment?
This trial tests if adding a specific cannabis product to standard methadone treatment helps people with opioid use disorder. It's for adults over 25 who recently started methadone and have used cannabis before.
Vancouver, British ColumbiaAges 25 years+ - NCT06819826RecruitingPhase 3
Study of SC0062 for IgA Nephropathy with Proteinuria
This trial tests an experimental drug (SC0062 capsule) for people with IgA nephropathy who have protein in their urine. It aims to see if the drug can help reduce kidney damage when added to standard treatments like blood pressure medications.
Guangzhou, Yuexiu DistrictAges 18 years+ - NCT07395687RecruitingPhase 2
Study of UBT251 for people with overweight or obesity
This trial tests different doses of UBT251, a new medicine, to see how well it helps people lose weight. It may be an option if you have overweight or obesity and meet certain age and BMI requirements.
Cypress, CaliforniaAges 18–65 - NCT07392372RecruitingPhase 1
Testing the safety of BNT351 in people with and without HIV
This trial tests a new antibody called BNT351 to see if it is safe and how it affects the immune system. It is for adults who either do not have HIV, or have HIV and are not currently on HIV medications.
Chicago, IllinoisAges 18–65 - NCT07397468RecruitingPhase 1/Phase 2
Study of JUV-161 for leg immobilization recovery
This trial tests a drug called JUV-161 to see if it can help protect muscle from loss when a leg is immobilized (in a cast or boot). It is for healthy adults who are willing to undergo a leg immobilization period and muscle biopsy.
AucklandAges 45–65 - NCT07397325RecruitingPhase 1/Phase 2
Study of a cooling cap to prevent hair loss from chemo
This trial tests a cooling cap (DA-020) to see if it can prevent hair loss during breast cancer chemotherapy. It may help you keep more of your hair while getting treatment.
ManausAges 18–65 - NCT07393126Recruiting
A trial of a supplement for mild urinary urgency in healthy Japanese adults
This study tests a product designed to support urinary health. The goal is to see if it helps reduce frequent urination and urgency in healthy Japanese adults who have mild bladder symptoms.
Nerima-ku, TokyoAges 18 years+ - NCT07390123RecruitingPhase 3
Study of HSK39297 for IgA Nephropathy (IgAN)
This trial tests an experimental tablet, HSK39297, for people with IgA nephropathy, a kidney disease. It aims to see if the drug is safe and can help reduce protein in the urine, which is a sign of kidney damage.
Huangshan City, AnhuiAges 18 years+ - NCT07390552RecruitingPhase 2
Study of PLH-2301 for muscle loss in older adults
This trial tests an experimental medicine called PLH-2301 to see if it can help improve muscle strength and function in people with age-related muscle loss (sarcopenia). It may be an option if you are 65 or older, have been diagnosed with sarcopenia, and can walk on your own.
Seongnam-si, Gyeonggi-doAges 65 years+ - NCT07391605RecruitingPhase 2
Descartes-08 for treatment-resistant myositis
This trial tests a new treatment called Descartes-08 for people with dermatomyositis or antisynthetase syndrome whose disease hasn't responded well to standard therapies. It aims to see if this treatment can help control muscle and skin symptoms.
Orange, CaliforniaAges 18 years+
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,905 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.